D. Poldermans et al., IMPROVED CARDIAC RISK STRATIFICATION IN MAJOR VASCULAR-SURGERY WITH DOBUTAMINE-ATROPINE STRESS ECHOCARDIOGRAPHY, Journal of the American College of Cardiology, 26(3), 1995, pp. 648-653
Objectives. This study sought to optimize preoperative cardiac risk st
ratification in a large group of consecutive candidates for vascular s
urgery by combining clinical risk assessment and semiquantitative dobu
tamine-atropine stress echocardiography. Background. Dobutamine-atropi
ne stress echocardiography has been used for the prediction of periope
rative cardiac risk in a small group of patients scheduled for electiv
e major vascular surgery on the basis of the presence or absence of st
ress-induced regional left ventricular wall motion abnormalities. Meth
ods. Clinical risk assessment and dobutamine-atropine stress echocardi
ography were performed in 302 consecutive patients presenting for majo
r vascular surgery. The extent and severity of stress wall motion abno
rmalities and the heart rate at which they occurred, in addition to th
e presence of wall motion abnormalities at rest, were assessed. Result
s. The absence of clinical risk factors (angina, diabetes, Q waves on
the electrocardiogram, symptomatic ventricular tachyarrhythmias, age >
70 years) identified a low risk group of 100 patients with a 1% cardia
c event rate (unstable angina). Dobutamine-atropine stress echocardiog
raphic findings were positive in 72 patients. Twenty-seven patients ha
d a perioperative cardiac event (cardiac death in 5, nonfatal infarcti
on in 12, unstable angina pectoris in 10); all 27 patients had positiv
e stress test results (positive predictive value 38%, negative predict
ive value 100%). The semiquantitative assessment of the extent and sev
erity of ischemia did not provide additional prognostic information in
patients with positive test results. In contrast, the heart rate at w
hich ischemia occurred defined a high risk group with a low ischemic t
hreshold (38 patients with 20 events [53%]) and an intermediate risk g
roup with a high ischemic threshold (34 patients with 7 events [21%]).
All 5 patients with a fatal outcome and 8 of 12 with a nonfatal myoca
rdial infarction were in the high risk group with a low ischemic thres
hold. Conclusions. Clinical variables identify 33% of patients at very
low risk for perioperative complications of vascular surgery in whom
further testing is redundant. In all other candidates, dobutamine-atro
pine stress echocardiography is a powerful tool that identifies those
patients at intermediate risk and a small group at very high risk. Ris
k stratification with a combination of clinical assessment and pharmac
ologic stress echocardiography has the potential to facilitate clinica
l decision making and conserve resources.